Maintenance Therapy with 13-cis Retinoid Acid in High-Grade Glioma at Complete Response After First-Line Multimodal Therapy – A Phase-II Study

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Neuro-Oncology

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/B:NEON.0000024748.26608.2fPMID 15174524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemoprevention of Breast Cancer with Fenretinide

  2012cited by this paper
• Malignant gliomas

  2004cited by this paper
• The efficacy of 9-cis-retinoic acid (aliretinoin) as a chemopreventive agent for cervical dysplasia: results of a randomized double-blind clinical trial.

  2003cited by this paper
• Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study.

  2003cited by this paper
• Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancer.

  2002cited by this paper
• Retinoic acid increases proliferation rate of GL‐15 glioma cells, involving activation of STAT‐3 transcription factor

  2002cited by this paper
• The WHO Classification of Tumors of the Nervous System

  2002cited by this paper
• Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma

  2002cited by this paper
• New advances in the treatment of acute promyelocytic leukemia

  2002cited by this paper
• Interferon-alpha2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma.

  2001cited by this paper
• Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells.

  2001cited by this paper
• Retinoids Induce Fibroblast Growth Factor-2 Production in Endothelial Cells via Retinoic Acid Receptor &agr; Activation and Stimulate Angiogenesis In Vitro and In Vivo

  2001cited by this paper
• Long‐term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin

  2001cited by this paper
• Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid.

  2001cited by this paper
• Effects of a novel synthetic retinoid on malignant glioma in vitro: inhibition of cell proliferation, induction of apoptosis and differentiation.

  2001cited by this paper
• Induction of heat shock proteins and its effects on glial differentiation in rat C6 glioblastoma cells.

  2001cited by this paper
• Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines.

  2000cited by this paper
• Human Malignant Glioma Cell Lines are Refractory to Retinoic Acid-Mediated Differentiation and Sensitization to Apoptosis1

  2000cited by this paper
• Lung cancer chemoprevention.

  2000cited by this paper
• Malignant gliomas

  2000cited by this paper
• Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer.

  2000cited by this paper
• Fenretinide activates caspases and induces apoptosis in gliomas.

  1999cited by this paper
• Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.

  1998cited by this paper
• Malignant glioma: Who benefits from adjuvant chemotherapy?

  1998cited by this paper
• Incomplete quality of life data in randomized trials: missing items.

  1998influential reference
• All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells.

  1998cited by this paper
• Effect of trans-retinoic acid and folic acid on apoptosis in human gastric cancer cell lines MKN-45 and MKN-28

  1998cited by this paper
• Retinoid-induced apoptosis in normal and neoplastic tissues

  1998cited by this paper
• Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

  1998cited by this paper
• The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin)

  1997cited by this paper
• Retinoic acid and the cyclin dependent kinase inhibitors synergistically alter proliferation and morphology of U343 astrocytoma cells

  1997cited by this paper
• All-trans-retinoic acid: a phase II radiation therapy oncology group study (RTOG 91-13) in patients with recurrent malignant astrocytoma

  1997cited by this paper
• All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications

  1997cited by this paper
• New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation

  1997cited by this paper
• Chemoprevention of breast cancer with fenretinide.

  1996cited by this paper
• Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.

  1996cited by this paper
• The role of chemotherapy in recurrent malignant gliomas: an overview.

  1996cited by this paper
• EORTC QLQ-C30 Scoring Manual

  1995cited by this paper
• Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate.

  1995cited by this paper
• Retinoids and chemoprevention: Clinical and basic studies

  1995cited by this paper
• Chemoprevention trials and surrogate end point biomarkers in the cervix

  1995cited by this paper
• Study of retinoic acid effect upon retinoic acid receptors beta (RAR-beta) in C6 cultured glioma cells.

  1995cited by this paper
• Trans retinoic acid inhibits in vivo tumour growth of C6 glioma in rats: effect negatively influenced by nerve growth factor.

  1994cited by this paper
• Solid tumours--chemoprevention with retinoids.

  1994cited by this paper
• Retinoids in cancer prevention and therapy.

  1992cited by this paper
• Response criteria for phase II studies of supratentorial malignant glioma.

  1990cited by this paper
• Inhibition of epidermal growth factor receptor activity by retinoic acid in glioma cells

  1990cited by this paper
• Effect of retinoids on the proliferation, morphology and expression of glial fibrillary acidic protein of an anaplastic astrocytoma cell line

  1988cited by this paper
• 13-Cis-retinoic acid: pharmacology, toxicology, and clinical applications for the prevention and treatment of human cancer.

  1985cited by this paper
• Core substructure in cyanobacterial phycobilisomes

  1983cited by this paper
• STUDIES ON THE MECHANISM OF INDUCTION OF EMBRYONAL CARCINOMA CELL DIFFERENTIATION BY RETINOIC ACID

  1981cited by this paper
• Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

  1980cited by this paper
• Retinoids inhibit the mitogenic activity of tumourpromoting phorbol esters on human lymphocytes

  1980cited by this paper
• Anti‐tumor potential of retinoic acid: Stimulation of immune mediated effectors

  1979cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment

  2024cites this paper
• Isotretinoin and neuropsychiatric side effects: Continued vigilance is needed

  2021cites this paper
• Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy

  2018cites this paper
• Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-κB axis

  2017cites this paper
• Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

  2016cites this paper
• Combined Treatment of ATRA with Epigenetic Drugs Increases Aggressiveness of Glioma Xenografts.

  2016cites this paper
• Impact of aldehyde Dehydrogenase isotypes on xenograft and syngeneic mouse models of humanprimary glioblastoma multiforme

  2016cites this paper
• Radiotherapy and temozolomide for anaplastic astrocytic gliomas

  2015cites this paper
• Retinoic acid signaling and neuronal differentiation

  2015cites this paper
• Isotretinoin maintenance therapy for glioblastoma: A retrospective review*

  2014cites this paper
• Extended adjuvant temozolomide with cis-retinoic acid for adult glioblastoma.

  2012cites this paper
• Maintenance therapy in solid tumors

  2012cites this paper
• An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting

  2011cites this paper
• Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05)

  2011cites this paper
• Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.

  2010cites this paper
• Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells

  2010cites this paper
• Biological therapy of glioblastoma

  2009cites this paper
• Therapeutic Approaches to Target Cancer Stem Cells

  2009cites this paper
• Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.

  2009cites this paper
• Genoma funcional e análise in silico na caracterização e no isolamento de genes envolvidos em gliomas humanos

  2006cites this paper
• Treatment Options for Glioblastoma and other Gliomas

  2006cites this paper
• Central nervous system tumors.

  2006cites this paper
• Non-cytotoxic drugs as potential treatments for gliomas

  2004cites this paper
• Differentiation Therapy Exerts Antitumor Effects on Stem-like Updated Version Material Supplementary Html Cited Articles E-mail Alerts

  year unknowncites this paper